For: | Choi SH, Choi GH, Kim SU, Park JY, Joo DJ, Ju MK, Kim MS, Choi JS, Han KH, Kim SI. Role of surgical resection for multiple hepatocellular carcinomas. World J Gastroenterol 2013; 19(3): 366-374 [PMID: 23372359 DOI: 10.3748/wjg.v19.i3.366] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i3/366.htm |
Number | Citing Articles |
1 |
Aditya Juloori, Rohan R. Katipally, Jeffrey M. Lemons, Anurag K. Singh, Renuka Iyer, Jared R. Robbins, Ben George, William A. Hall, Sean P. Pitroda, Fauzia Arif, John Fung, Anjana Pillai, Chih-Yi Liao, Manish Sharma, Stanley L. Liauw. Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2023; 115(1): 202 doi: 10.1016/j.ijrobp.2022.09.052
|
2 |
Takeshi Takamoto, Yasuhiko Sugawara, Takuya Hashimoto, Masatoshi Makuuchi. Evaluating the current surgical strategies for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2016; 10(3): 341 doi: 10.1586/17474124.2016.1116381
|
3 |
Na Reum Kim, Seoung Yoon Rho, Jonathan Navarro, Chansik An, Dai Hoon Han, Jin Sub Choi, Myeong-Jin Kim, Gi Hong Choi. Additional nodules detected using EOB-MRI in patients with resectable single hepatocellular carcinoma: an implication for active treatment strategy. Journal of Liver Cancer 2024; 24(1): 92 doi: 10.17998/jlc.2024.01.25
|
4 |
Wei-Fan Hsu, Kai-Chih Chang, Te-Hong Chen, Chien-Hung Lin, Ying-Chun Lin, Ming-Hung Tsai, Pei-Yu Chen, Hung-Wei Wang, Chia-Sheng Chu, Cheng-Yuan Peng. Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma. Medicine 2021; 100(33): e27000 doi: 10.1097/MD.0000000000027000
|
5 |
Sasan Roayaie. TACE vs. surgical resection for BCLC stage B HCC. Journal of Hepatology 2014; 61(1): 3 doi: 10.1016/j.jhep.2014.04.005
|
6 |
Matteo Donadon, Andrea Fontana, Fabio Procopio, Daniele Del Fabbro, Matteo Cimino, Luca Viganò, Angela Palmisano, Guido Torzilli. Dissecting the multinodular hepatocellular carcinoma subset: is there a survival benefit after hepatectomy?. Updates in Surgery 2019; 71(1): 57 doi: 10.1007/s13304-019-00626-3
|
7 |
G.K. Glantzounis, A. Paliouras, M.-C. Stylianidi, H. Milionis, P. Tzimas, D. Roukos, G. Pentheroudakis, E. Felekouras. The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review. European Journal of Surgical Oncology 2018; 44(2): 195 doi: 10.1016/j.ejso.2017.11.022
|
8 |
Antonio Facciorusso, Raffaele Licinio, Nicola Muscatiello, Alfredo Di Leo, Michele Barone. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. World Journal of Hepatology 2015; 7(16): 2009-2019 doi: 10.4254/wjh.v7.i16.2009
|
9 |
Basma Fathy Mohamed, Waleed Mohamed Serag, Reda Mahamoud Abdelal, Heba Fadl Elsergany. S100A14 protein as diagnostic and prognostic marker in hepatocellular carcinoma. Egyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0015-6
|
10 |
François Cauchy, Olivier Soubrane, Jacques Belghiti. Liver resection for HCC: Patient's selection and controversial scenarios. Best Practice & Research Clinical Gastroenterology 2014; 28(5): 881 doi: 10.1016/j.bpg.2014.08.013
|
11 |
Ming-Chih Ho, Kiyoshi Hasegawa, Xiao-Ping Chen, Hiroaki Nagano, Young-Joo Lee, Gar-Yang Chau, Jian Zhou, Chih-Chi Wang, Young Rok Choi, Ronnie Tung-Ping Poon, Norihiro Kokudo. Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). Liver Cancer 2016; 5(4): 245 doi: 10.1159/000449336
|
12 |
Ilenia Bartolini, Tommaso Nelli, Nadia Russolillo, Alessandro Cucchetti, Benedetta Pesi, Luca Moraldi, Alessandro Ferrero, Giorgio Ercolani, Gianluca Grazi, Giacomo Batignani. Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study. The American Journal of Surgery 2021; 222(3): 599 doi: 10.1016/j.amjsurg.2021.01.023
|
13 |
Jian-Hong Zhong, Fei-Xiang Wu, Hang Li. Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma. Tumor Biology 2014; 35(9): 8355 doi: 10.1007/s13277-014-2571-z
|
14 |
Fabrizio Romano, Marco Chiarelli, Mattia Garancini, Mauro Scotti, Mauro Zago, Gerardo Cioffi, Matilde De Simone, Ugo Cioffi. Rethinking the Barcelona clinic liver cancer guidelines: Intermediate stage and Child-Pugh B patients are suitable for surgery?. World Journal of Gastroenterology 2021; 27(21): 2784-2794 doi: 10.3748/wjg.v27.i21.2784
|
15 |
Satoshi Yasuda, Takeo Nomi, Daisuke Hokuto, Ichiro Yamato, Shinsaku Obara, Takatsugu Yamada, Hiromichi Kanehiro, Yoshiyuki Nakajima. Huge hepatocellular carcinoma with multiple intrahepatic metastases: An aggressive multimodal treatment. International Journal of Surgery Case Reports 2015; 16: 44 doi: 10.1016/j.ijscr.2015.09.016
|
16 |
Ya Ruth Huo, Michael Vinchill Chan, Christine Chan. Resection Plus Post-operative Adjuvant Transcatheter Arterial Chemoembolization (TACE) Compared with Resection Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. CardioVascular and Interventional Radiology 2020; 43(4): 572 doi: 10.1007/s00270-019-02392-6
|
17 |
Chuan Li, Tian-Fu Wen, Lv-Nan Yan, Wu-Sheng Lu, Bo Li, Wen-Tao Wang, Ming-Qing Xu, Jia-Yin Yang. Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria. Journal of Surgical Research 2017; 209: 8 doi: 10.1016/j.jss.2016.09.054
|
18 |
Javier Tejeda-Maldonado, Ignacio García-Juárez, Jonathan Aguirre-Valadez, Adrián González-Aguirre, Mario Vilatobá-Chapa, Alejandra Armengol-Alonso, Francisco Escobar-Penagos, Aldo Torre, Juan Francisco Sánchez-Ávila, Diego Luis Carrillo-Pérez. Diagnosis and treatment of hepatocellular carcinoma: An update. World Journal of Hepatology 2015; 7(3): 362-376 doi: 10.4254/wjh.v7.i3.362
|
19 |
Takao Ohkubo, Yutaka Midorikawa, Hisashi Nakayama, Masamichi Moriguchi, Osamu Aramaki, Shintaro Yamazaki, Tokio Higaki, Tadatoshi Takayama. Liver resection of hepatocellular carcinoma in patients with portal hypertension and multiple tumors. Hepatology Research 2018; 48(6): 433 doi: 10.1111/hepr.13047
|
20 |
Satoshi Matsukuma, Kazuhiko Sakamoto, Yoshihiro Tokuhisa, Yukio Tokumitsu, Hiroto Matsui, Shinsuke Kanekiyo, Shinobu Tomochika, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Tomio Ueno, Hiroshi Wada, Shogo Kobayashi, Issei Saeki, Hidetoshi Eguchi, Masato Sakon, Isao Sakaida, Hiroaki Nagano. Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer‑B hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9420
|
21 |
B. N. Kotiv, I. I. Dzidzava, S. A. Alent’yev, A. V. Smorodsky, K. I. Makhmudov, A. A. Apollonov, S. A. Soldatov, P. N. Zubarev. Complex treatment of hepatocellular carcinoma at early (BCLC-A) and intermediate (BCLC-B) stages. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 55 doi: 10.16931/1995-5464.2020255-66
|
22 |
Ya-Peng Qi, Jian-Hong Zhong, Zhi-Yin Liang, Jie Zhang, Bin Chen, Chang-Zhi Chen, Le-Qun Li, Bang-De Xiang. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion. The American Journal of Surgery 2019; 217(4): 739 doi: 10.1016/j.amjsurg.2018.07.054
|
23 |
Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B. Clinical and Molecular Hepatology 2019; 25(4): 390 doi: 10.3350/cmh.2018.0103
|
24 |
Xingshun Qi, Diya Wang, Chunping Su, Hongyu Li, Xiaozhong Guo. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Oncotarget 2015; 6(21): 18715 doi: 10.18632/oncotarget.4134
|
25 |
Josep Fuster. Surgical Treatment of Hepatocellular Carcinoma: Should Resection be Performed According to Barcelona Clinic Liver Cancer Classification?. Hepatic Oncology 2015; 2(3): 245 doi: 10.2217/hep.15.18
|
26 |
Li Jiang, Lunan Yan, Tianfu Wen, Bo Li, Yong Zeng, Jiayin Yang, Wentao Wang, Mingqing Xu, Hong Wu. Comparison of Outcomes of Hepatic Resection and Radiofrequency Ablation for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the Barcelona-Clinic Liver Cancer Stage A Classification. Journal of the American College of Surgeons 2015; 221(5): 951 doi: 10.1016/j.jamcollsurg.2015.08.009
|
27 |
Brian K.P. Goh, Pierce K.H. Chow, Jin-Yao Teo, Jen-San Wong, Chung-Yip Chan, Peng-Chung Cheow, Alexander Y.F. Chung, London L.P.J. Ooi. Number of Nodules, Child-Pugh Status, Margin Positivity, and Microvascular Invasion, but not Tumor Size, are Prognostic Factors of Survival after Liver Resection for Multifocal Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2014; 18(8): 1477 doi: 10.1007/s11605-014-2542-0
|
28 |
Sasan Roayaie, Ghalib Jibara, Parissa Tabrizian, Joong‐Won Park, Jijin Yang, Lunan Yan, Myron Schwartz, Guohong Han, Francesco Izzo, Mishan Chen, Jean‐Frédéric Blanc, Philip Johnson, Masatoshi Kudo, Lewis R. Roberts, Morris Sherman. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 2015; 62(2): 440 doi: 10.1002/hep.27745
|
29 |
Xiaomeng Xie, Mingjie Yao, Xiangmei Chen, Weiquan Lu, Quanjun Lv, Kaijuan Wang, Ling Zhang, Fengmin Lu. Reduced Red Blood Cell Count Predicts Poor Survival After Surgery in Patients With Primary Liver Cancer. Medicine 2015; 94(8): e577 doi: 10.1097/MD.0000000000000577
|
30 |
Chetana Lim, Chady Salloum, Michael Osseis, Eylon Lahat, Concepción Gómez-Gavara, Philippe Compagnon, Alain Luciani, Cyrille Feray, Daniel Azoulay. Short-term outcomes following hepatectomy for hepatocellular carcinoma within and beyond the BCLC guidelines. HPB 2018; 20(3): 222 doi: 10.1016/j.hpb.2017.08.027
|
31 |
Arvind R. Murali, Sanjeev Patil, Kirk T. Phillips, Michael D. Voigt. Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma. Transplantation 2017; 101(8): e249 doi: 10.1097/TP.0000000000001730
|
32 |
Ling Zhang, Jianming Hu, Jingyu Hou, Xinhua Jiang, Lei Guo, Li Tian. Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection. Abdominal Radiology 2021; 46(8): 3845 doi: 10.1007/s00261-021-03034-7
|
33 |
Joo Hyun Oh, Dong Hyun Sinn, Gyu-Seong Choi, Jong Man Kim, Jae-Won Joh, Tae Wook Kang, Dongho Hyun, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi. Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria. Annals of Surgical Treatment and Research 2020; 99(4): 238 doi: 10.4174/astr.2020.99.4.238
|
34 |
Zhang Zhaohui, Shen Shunli, Chen Bin, Li Shaoqiang, Hua Yunpeng, Kuang Ming, Liang Lijian, Peng Bao Gang. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients. Cancer Research and Treatment 2019; 51(1): 65 doi: 10.4143/crt.2018.038
|
35 |
Teodor Kapitanov, Ulf P. Neumann, Maximilian Schmeding. Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization—A Meta-Analysis. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/696120
|